Pressure Building for Firms to Disclose Clinical Trial Results

Drug Industry Daily
KEYWORDS FDA / Trial
A A

The benefits of disclosing clinical trial results on ClinicalTrials.gov outweigh the risks, but the industry now faces an information glut as drug companies begin to publish all data connected to trials, whether scientific or not, in an effort to avoid liability.

To View This Article:

Login

Subscribe To Drug Industry Daily